Results 321 to 330 of about 211,753 (383)

Estimation of adverse drug reaction reporting in Iran: Correction for underreporting

Pharmacoepidemiology and Drug Safety, 2021
Underreporting of Adverse Drug Reactions (ADRs) reduces the sensitivity of pharmacovigilance systems. We described ADR reporting and its trend from 1999 to 2017 and estimated the ADR underreporting in the Iranian Pharmacovigilance Center.
Malahat Khalili, B. Mesgarpour, H. Sharifi, Asieh Golozar, A. Haghdoost   +4 more
semanticscholar   +1 more source

ASHP Guidelines on Adverse Drug Reaction Monitoring and Reporting.

American Journal of Health-System Pharmacy, 2021
Pharmacists have the knowledge and expertise needed to develop and organize comprehensive programs that monitor, report, and evaluate adverse drug reactions (ADRs) in health systems.
Ly Lee, D. Carias, Rena A. Gosser, Ambra Hannah, Sarah Stephens, William A Templeman   +5 more
semanticscholar   +1 more source

Adverse reactions to cosmetics reported to the Chongqing adverse drug reaction monitoring centre system in China

Contact Dermatitis, 2022
AbstractBackgroundCosmetic adverse reactions (CARs) are becoming widespread in China. However, a comprehensive analysis of data is lacking.ObjectiveTo analyse the clinical characteristics of patients with reported adverse reactions to cosmetics in Chongqing, China.MethodsCases with CARs reported to the Chongqing Adverse Drug Reaction Monitoring Centre ...
Sha Wang, Yang Jiang, Jing Lyu, Jiajia Li, Qingchun Diao   +4 more
openaire   +2 more sources

Evolution of Adverse drug reactions reporting systems: Paper-based to software-based

European Journal of Clinical Pharmacology, 2022
Abstract Adverse Drug Reactions (ADR) add a significant clinical and economic burden to the healthcare system of a country. Reporting ADRs is the cornerstone of detecting uncommon ADRs once the drugs are on the market. In many countries, ADR reporting is regulated by national regulatory bodies and various methods are employed to report ADRs.
M. T. Madhushika, T. P. Weerarathna, P. L. G. C. Liyanage, S. S. Jayasinghe   +3 more
openaire   +2 more sources

Systemic Barriers and Potential Concerns from Reporting Serious Adverse Drug Reactions

2022
About 1-10% of all serious adverse drug reactions (sADRs) are reported to the Food and Drug Administration (FDA) ( Moore T, Bennett C. Underreporting of Hemorrhagic and Thrombotic Complications of Pharmaceuticals to the U.S. Food and Drug Administration: Empirical Findings for Warfarin, Clopidogrel, Ticlopidine, and Thalidomide from the Southern ...
Matthew A, Taylor, Ashley C, Godwin, Shamia, Hoque, Charles L, Bennett   +3 more
openaire   +2 more sources

Assessing Adverse Drug Reactions Reported for New Respiratory Medications in the FDA Adverse Event Reporting System Database

Respiratory Care, 2021
Between 2012 and 2017, 25 new medications or combination products were approved by the Food and Drug Administration (FDA) for use in treatment of chronic lower respiratory diseases (CLRDs). With limited data on post-marketing patient exposure to these drugs, their safety profiles remain unknown. This study aims to provide post-marketing surveillance of
Hyunwoo, Kim, Colin M, Pfeiffer, Matthew P, Gray, Britney A, Stottlemyer, Richard D, Boyce, Sandra L, Kane-Gill   +5 more
openaire   +2 more sources

Identifying adverse reactions to drugs reporting systems

Clinics in Dermatology, 1986
Abstract The dermatologist's concern about adverse reactions to drugs can be viewed from two perspectives. Most often, dermatologists are confronted with skin reactions to drugs used in the treatment of a wide variety of noncutaneous diseases. Less frequently, but sometimes more dramatically, dermatologists care for a patient who may have developed a ...
openaire   +2 more sources

Adverse reactions to isotretinoin. A report from the Adverse Drug Reaction Reporting System.

Journal of the American Academy of Dermatology, 1988
Between October 1982 and June 1985 the Adverse Drug Reaction Reporting System received reports of 104 suspected adverse reactions occurring in 93 patients who took isotretinoin. Adverse reactions involving the skin and mucous membranes (29 reports), central nervous system (23), musculoskeletal system (12), pregnancy (11), and eyes (8) were most ...
M, Bigby, R S, Stern
openaire   +1 more source